Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
@amateur.invest- seems your name is very accurate. Particularly the 'amateur' part.
Easy to antagonize people on a board in the virtual world hidden behind a made up name
Do you do anything useful in the real world?
It was perfectly appropriate?
The extra money hes generated for the purchase of said house should no doubt ensure it’s built on affirmer foundation ha ha
PL75 also reported for inappropriate use of words.
Amateur, no point in asking him as he’s full of ****e. Claims to own a PLC? The fact that you associate yourself with him says a lot about you too! Now I know times must be hard over at Chipperfield’s due to this pandemic but would you awfully mind moonlighting somewhere else?
Golferboy, I never thought you’d have enough neck to show your face around here again after I outed your lies the other day? Didn’t you claim that you owned a company that is listed on the London Stock Exchange?
Oh! I now understand Sir Al, he meant summer of 2021, he was misunderstood speaking with that heavy Yorkshire accent whilst sipping his Yorkshire tea. We get ya now.
Following completion of tech transfer from Avacta and Cytiva to BBI, an initial batch of 10,000 LFTs will be manufactured. These will be used to run the two studies – professional use clinical validation, and the lay user study – in parallel. The former will likely be run in several hospitals across the UK. Assuming priority access to patient samples is granted over other IVD MDs being clinically validated, it could be completed in less than two weeks. The lay user study, on the other hand, will likely take at least one month to complete, in our view.
Ceo's house might be finished by then !
Yup, dvrg depend on avacta. I know that, and avacta will most likely take all the profit from them. Win all round.
LOL
You need to choose a lollipop.
1 Make money favoured.
2 DVRG effluenced flavour - with hint of "window licker"..
Now - is it the Blue Pill - or the Red?
Good luck in your investments in the future - and er try and keep it classy.
3
Do all at home use lft’s tests require MHRA approval for home use as this alone is 90 days.
Well said red, aptamer /affimer testing v conventional PCR testing will throw up completely different results, and will confuse common ppl. For Aptamer / affimer testing , it will take time for this to be accepted as the industry norm. avct, dvrg, brh, etc are all the right area for next generation testing growth though.
And does he think that 90% of hospital admissions are false hospital admissions, and 90% of the deaths are false deaths?
(no offense intended to anybody).
Hi all, this is my first post and possibly pure speculation as I don't have a technical background but I wondered what those of you with technical backgrounds think of this:
According to Dr Michael Yeadon's work, 90% or more of the positives thrown up by the PCR testing methods used by the authorities are false positives.
According to DS, affimers are exquisitely specific. So Avacta's affimer reagents could well be more specific than the PCR tests and therefore do not throw up so many false positives.
So there is a difference in the results when the affimer tests are evaluated next to the PCR test.
Whoever is responsible for evaluating the tests might conclude that as the PCR test is the gold standard, the Avacta test is deficient.
Now in order to pass the validation DS has got to convince officialdom that their PCR test is deficient.
What an uphill task that must be.
As this crisis has demonstrated time and again, those in authority do not like to have to change their minds.
It may take a complete overhaul of the entire civil service before Avacta gets approval.
We could be in for a long wait.